X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5383) 5383
Publication (409) 409
Newsletter (64) 64
Book Chapter (25) 25
Book Review (22) 22
Conference Proceeding (12) 12
Newspaper Article (8) 8
Book / eBook (5) 5
Dissertation (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3763) 3763
humans (1935) 1935
mice (1592) 1592
gangliosides (1542) 1542
rats (1456) 1456
male (1038) 1038
gangliosides - pharmacology (1031) 1031
biochemistry & molecular biology (1017) 1017
index medicus (951) 951
gangliosides - metabolism (853) 853
neurosciences (787) 787
g ganglioside - pharmacology (780) 780
female (760) 760
cells, cultured (752) 752
ganglioside (642) 642
g ganglioside - metabolism (565) 565
pharmacology & pharmacy (524) 524
cell line (491) 491
immunology (452) 452
kinetics (429) 429
cell biology (365) 365
oncology (340) 340
tumor cells, cultured (335) 335
time factors (317) 317
cells (314) 314
molecular sequence data (313) 313
expression (312) 312
dose-response relationship, drug (305) 305
cell membrane - metabolism (302) 302
gangliosides - immunology (302) 302
mice, inbred c57bl (297) 297
lipids (292) 292
brain (286) 286
gm1 ganglioside (285) 285
neurons - drug effects (283) 283
cattle (274) 274
glycosphingolipids (271) 271
apoptosis (256) 256
proteins (252) 252
cell line, tumor (250) 250
mice, inbred balb c (246) 246
brain - metabolism (245) 245
in vitro techniques (245) 245
rats, sprague-dawley (245) 245
rats, inbred strains (239) 239
g ganglioside - immunology (229) 229
medicine, research & experimental (227) 227
neurons (227) 227
chromatography, thin layer (224) 224
rats, wistar (223) 223
analysis (221) 221
phosphorylation (219) 219
neurons - metabolism (214) 214
cancer (213) 213
activation (212) 212
signal transduction (211) 211
carbohydrate sequence (208) 208
research (207) 207
binding (203) 203
differentiation (199) 199
biophysics (196) 196
cell division - drug effects (196) 196
gangliosides - analysis (196) 196
enzyme inhibitors - pharmacology (195) 195
receptor (193) 193
ganglioside gm1 (192) 192
protein binding (190) 190
g ganglioside (189) 189
gangliosides - biosynthesis (187) 187
cholera toxin - pharmacology (184) 184
inhibition (183) 183
research article (182) 182
killer cells, natural - immunology (181) 181
cell differentiation - drug effects (178) 178
lipid rafts (178) 178
gangliosides - physiology (174) 174
article (173) 173
growth (167) 167
binding sites (165) 165
disease models, animal (164) 164
gm1 (164) 164
brain - drug effects (162) 162
protein (161) 161
immunohistochemistry (157) 157
antibodies (156) 156
flow cytometry (156) 156
neuraminidase - pharmacology (156) 156
cell survival - drug effects (155) 155
multidisciplinary sciences (154) 154
neuroblastoma (154) 154
membrane microdomains - metabolism (153) 153
calcium - metabolism (151) 151
rabbits (151) 151
cholesterol (149) 149
glycosphingolipids - metabolism (149) 149
gangliosides - chemistry (147) 147
physiological aspects (144) 144
chemistry, medicinal (142) 142
neurons - cytology (142) 142
glycolipids (140) 140
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5311) 5311
Japanese (142) 142
Russian (97) 97
Chinese (13) 13
German (12) 12
Spanish (7) 7
French (5) 5
Polish (3) 3
Italian (2) 2
Portuguese (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroscience, ISSN 0270-6474, 06/2009, Volume 29, Issue 24, pp. 7898 - 7908
Glutamate released from synaptic vesicles mediates excitatory neurotransmission by stimulating glutamate receptors. Glutamate transporters maintain low... 
AMINO-ACID TRANSPORTER | NMDA RECEPTORS | GLUTATHIONE DEFICIENCY | CEREBRAL WHITE-MATTER | HIGH-AFFINITY | RECEPTOR SUBUNIT EXPRESSION | CENTRAL-NERVOUS-SYSTEM | DEVELOPMENTAL REGULATION | REGIONAL SUSCEPTIBILITY | NEUROSCIENCES | HYPOXIC/ISCHEMIC INJURY | Excitatory Amino Acid Transporter 3 - physiology | Oligodendroglia - metabolism | Excitatory Amino Acid Transporter 2 - physiology | O Antigens - metabolism | Rats, Long-Evans | Kainic Acid - analogs & derivatives | Brain - growth & development | Patch-Clamp Techniques - methods | Quinoxalines - pharmacology | Fibroblast Growth Factors - metabolism | Tritium - metabolism | Excitatory Amino Acid Transporter 3 - antagonists & inhibitors | Gangliosides - metabolism | Female | Neurons - metabolism | Tetrodotoxin - pharmacology | Gene Expression Regulation, Developmental - physiology | Animals, Newborn | Membrane Potentials - drug effects | Brain - cytology | Benzodiazepines - pharmacology | Excitatory Amino Acid Transporter 2 - antagonists & inhibitors | Kainic Acid - pharmacology | Cells, Cultured | Gene Expression Regulation, Developmental - drug effects | Rats | Sodium Channel Blockers - pharmacology | Excitatory Amino Acid Antagonists - pharmacology | Bicuculline - pharmacology | Membrane Potentials - physiology | GABA Antagonists - pharmacology | Pregnancy | Platelet-Derived Growth Factor - metabolism | Animals | Glutamic Acid - metabolism | Aspartic Acid - pharmacology | Index Medicus
Journal Article
Journal Article
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 2007, Volume 73, Issue 4, pp. 534 - 549
Journal Article
Journal Article
American Journal of Health-System Pharmacy, ISSN 1079-2082, 04/2017, Volume 74, Issue 8, pp. 563 - 567
PURPOSE.The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric... 
Dinutuximab | Neuroblastoma | INTERLEUKIN-2 | TRIAL | neuroblastoma | LYSIS | ANTIBODY | PHARMACOLOGY & PHARMACY | dinutuximab | HIGH-RISK NEUROBLASTOMA | CHEMOTHERAPY | TRANSPLANTATION | AGE | Gangliosides - antagonists & inhibitors | Immunotherapy - methods | Isotretinoin - therapeutic use | Antigens, Neoplasm - immunology | Isotretinoin - pharmacology | Antibodies, Monoclonal - pharmacology | Humans | Interleukin-2 - therapeutic use | Antibodies, Monoclonal - therapeutic use | Neuroblastoma - mortality | Gangliosides - immunology | Antineoplastic Agents, Immunological - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Disease-Free Survival | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Maintenance Chemotherapy - methods | Antineoplastic Agents, Immunological - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Neuroblastoma - immunology | Interleukin-2 - pharmacology | Granulocyte-Macrophage Colony-Stimulating Factor - antagonists & inhibitors | Child | Treatment outcome | Research | Drug therapy | Analysis | Therapy | Pediatrics | Toxicity | Interleukin | Clinical trials | Cytotoxicity | Risk | Neuropathy | Dosage | Macrophages | Infusion | Pain | Interleukin 2 | Immunotherapy | Myelosuppression | Colony-stimulating factor | Antibody-dependent cell-mediated cytotoxicity | Medical research | Risk groups | Granulocyte-macrophage colony-stimulating factor | Abnormalities | Pharmacology | Maintenance | Patients | Fever | Antigen (tumor-associated) | Monoclonal antibodies | Electrolytes
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2012, Volume 18, Issue 10, pp. 2740 - 2753
Journal Article
Journal Article
Brain Research, ISSN 0006-8993, 2008, Volume 1244, pp. 13 - 23
Journal Article
Journal Article
Journal Article
Current Opinion in Pharmacology, ISSN 1471-4892, 08/2018, Volume 41, pp. 42 - 51
Most infections are caused by pathogens that access the body at mucosal sites. Hence, development of mucosal vaccines to prevent local infection or invasion of... 
HEAT-LABILE ENTEROTOXIN | DENDRITIC CELLS | CHOLERA-TOXIN ADJUVANT | HELICOBACTER-PYLORI INFECTION | CTA1-DD ADJUVANT | PHARMACOLOGY & PHARMACY | INFLUENZA VACCINE | ESCHERICHIA-COLI ETEC | B-SUBUNIT | SYSTEMIC IMMUNE-RESPONSES | MUCOSAL ADJUVANT | Adjuvants, Immunologic - pharmacology | Enterotoxins - toxicity | Humans | Immunity, Mucosal | Bacterial Toxins - toxicity | Adjuvants, Immunologic - toxicity | ADP-Ribosylation | Cholera Toxin - toxicity | Bacterial Toxins - chemistry | Adjuvants, Immunologic - chemistry | Bacterial Toxins - pharmacology | Escherichia coli Proteins - pharmacology | Cholera Toxin - chemistry | Cholera Toxin - pharmacology | Escherichia coli Proteins - toxicity | Enterotoxins - chemistry | Escherichia coli Proteins - chemistry | Enterotoxins - pharmacology | Vaccines | Cholera toxin | Gene mutations | T cells | Adenosine triphosphatase | interleukin 12 | CD40 antigen | lymphocyte differentiation | Escherichia coli | interleukin 17 | guanine nucleotide binding protein | Th2 cell | chemokine receptor CCR4 | B7 antigen | STAT3 protein | interleukin 6 | interleukin 5 | interleukin 4 | conformational transition | endoplasmic reticulum associated degradation | enzyme activity | upregulation | cyclic AMP | endocytosis | protein expression | interleukin 10 | protein protein interaction | enterotoxin | protein cleavage | CXCL13 chemokine | chemokine receptor CCR7 | nonhuman | unclassified drug | humoral immunity | gamma interferon | CD86 antigen | Th17 cell | major histocompatibility antigen class 2 | Vibrio cholerae | Immunologi inom det medicinska området | Review | immunological adjuvant | enzyme conformation | disulfide bond | cyclic AMP responsive element binding protein | ganglioside GM1 | priority journal | Immunology in the medical area | interleukin 23 | adenosine diphosphate ribosylation factor 6 | nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase | cellular immunity | protein binding | interferon consensus sequence binding protein | nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase A1 | nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase A2 | cystic fibrosis transmembrane conductance regulator | adenosine diphosphate ribosylation | Th1 cell | endoplasmic reticulum
Journal Article